Food and Drug Administration Approval of Glutamine for Sickle Cell Disease: Success and Precautions in Glutamine Research

Journal of Parenteral and Enteral Nutrition

Volumn 41, Issue 6, 2017, Pages 912-917

  Wilmore, Douglas W ^a  

^a NONE   (United States)

Author keywords

amino acids; enteral nutrition; glutamine; immunonutrition; nutrition; nutrition and disease; parenteral nutrition

Indexed keywords

GLUTAMINE;

CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG APPROVAL; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; ENTERIC FEEDING; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; RESEARCH; UNITED STATES;

ANEMIA, SICKLE CELL; DRUG APPROVAL; ENTERAL NUTRITION; GLUTAMINE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PARENTERAL NUTRITION; RESEARCH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85030693051     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607117727271     Document Type: Note

References (39)

1. Niihara Y, Zarez CR, Aldyama DS, Tanaka KR., Oral L-glutamine therapy for sickle cell anemia: subjective clinical improvement and favorable change in red cell NAD redox potential. Am J Hematol. 1998; 58: 117-121.
2. Niihara Y, Matsui NM, Shen YM, et al. L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells. BMC Blood Disord. 2005; 5: 4.
3. Schulze E, Bosshard E., Uber das Glutam. Landwirtsh Vers Sta. 1883; 29: 295-307.
4. Damodaran M, Jaaback G, Chibnall AC., The isolation of glutamine form an enzymatic digest of gliadin. Biochem J. 1932; 26: 1704-1713.
5. Krebs H,. Special lecture: glutamine metabolism in the animal body. In: Mora J, Palacios R, eds. Glutamine: Metabolism, Enzymology, and Regulation. New York, NY: Academic Press; 1980: 319-329.
6. Eagle H, Oyama VI, Levy M, Horton CI, Fleischman R., The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. J Biol Chem. 1956; 218: 607-616.
7. Windmueller HG, Spaeth AE., Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem. 1974; 249: 5070-5079.
8. O'Dwyer ST, Smith RJ, Hwang TL, Wilmore DW., Maintenance of small bowel mucosa with glutamine enriched parenteral nutrition. JPEN J Parenter Enteral Nutr. 1989; 13: 579-585.
9. Wang X-D, Jacobs DO, O'Dwyer ST, Smith RJ, Wilmore DW., Glutamine-enriched parenteral nutrition prevents mucosal atrophy following massive small bowel resection. Surg Forum. 1988; 39: 44-46.
10. Zhou Y-P, Jiang ZM, Sun Y-H, Wang X-R, Ma E-L, Wilmore DW., The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003; 27: 241-245.
11. Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome. Ann Surg. 2005; 242: 655-661.
12. Ardawi MSM, Newsholme EA., Glutamine metabolism in lymphocytes of the rat. Biochem J. 1983; 212: 835-842.
13. Newsholme P, Newsholme EA., Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem J. 1989; 261: 211-218.
14. Bergstrom J, Furst P, Noree L-O, Vinners E., Intracellular free amino acid concentrations in human muscle tissue. J Appl Physiol. 1974; 36: 693-697.
15. Fürst P, Albers S, Stehle P., Evidence for a nutritional need for glutamine in catabolic patients. Kidney Int Suppl. 1989; 27: S287-S292.
16. Hammarqvist F, Wernerman J, Ali R, von der Decken A, Vinnars E., Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis and improves nitrogen balance. Ann Surg. 1989; 209: 455-461.
17. Lacey JM, Wilmore DW., Is glutamine a conditionally essential amino acid? Nutr Rev. 1990; 48: 297-309.
18. Fürst P, Stehle P., What are the essential elements needed for the determination of amino acid requirements in humans? J Nutr Suppl. 2004; 134: 1558S-1565S.
19. Fürst P, Stehle P., The potential use of parenteral dipeptides in clinical nutrition. Nutr Clin Pract. 1993; 8: 106-114.
20. Yao G-X, Xue X-B, Jiang Z-M, Yang N-F, Wilmore DW., Effects of perioperative parenteral glutamine-dipeptide supplementation on plasma endotoxin level, plasma endotoxin iactivation capacity and clinical outcome. Clin Nutr. 2005; 24: 510-515.
21. Stehle P, Zander J, Mertes N, et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989; 1: 231-233.
22. Tao KM, Li XQ, Yang LQ, et al. Glutamine supplementation for critically ill adults. Cochrane Database Syst Rev. 2014;(9): CD0100.
23. Chen QH, Yang Y, He HL, et al. The effect of glutamine therapy on outcomes in critically ill patients: a meta-analyais of randomized controlled trials. Crit Care. 2014; 18: 436.
24. Stehle P, Ellger B, Kojic D, et al. Glutamine dipeptide-supplemented parenteral nutrition improvest the clinical outcomes of critically ill patients: a systematic evaluation of randomized controlled trials. Clin Nutr ESPEN. 2017; 17: 75-85.
25. McRae MP., Therapeutic benefits of glutamine: an umbrella review of meta-analyses. Biomed Rep. 2017; 6: 576-584.
26. van Zanten AR, Dhaliwal R, Garrel D, Heyland DK., Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care. 2015; 19: 294.
27. Heyland DK, Dhaliwal R, Day Ag, et al. Reducing deaths due to oxidative stress (the REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc. 2006; 65: 250-263.
28. Heyland DK, Dhaliwalm R, Day A, Drover J, Cote H, Wischmeyer P., Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase 1 dose-finding study. JPEN J Parenter Enteral Nutr. 2007; 31: 109-118.
29. Soguel L, Chiolero RL, Ruffieux C, Berger MM., Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn and burn patients. Nutrition. 2008; 24: 1123-1132.
30. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Eng J Med. 2013; 368: 1489-1497.
31. Wischmeyer P, Dhaliwai R, McCall M, Ziegler TR, Heyland DK., Parenteral glutamine supplementation in critical illness: a systemic review. Crit Care. 2014; 18: R76.
32. Bistrian BR., Glutamine and antioxidants in critically ill patients. N Engl J Med. 2013; 369: 482-484.
33. Hyland DL, Elke G, Cook D, et al. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2015; 39: 401-409.
34. Niihara Y, Macan H, Eckman JR, et al. L-glutamine therapy reduces hospitlization for sickle cell anemia and sickle β°-thalasssemia patients at six months-a phase II randomized trial. Clin Pharmacol Biopham. 2014; 3: 1-5.
35. Emmaus Medical. Oral L-Glutamine Powder for the Treatment of Sickle Cell Disease. Torrance, CA: Emmaus Medical; 2017. Sponsors briefing document NDA 208587.
36. Lenders CM, Liu S, Wilmore DW, et al. Evaluation of a novel food composition database that includes glutamine and other amino acids derived from gene sequencing data. Eur J Clin Nutr. 2009; 63: 1433-1439.
37. Lenders C, Hu FB, Willet WC, et al. Relations of dietary type of protein, glutamine, and glutamate to the incidence of type 2 diabetes mellitus among middle-aged women. FASEB J. 2008; 22: 299.
38. Lenders C., A Novel Food Composition Database to Study the Relationships between Types of Protein, Amino acids, Weight Gain, and Type 2 Diabetes Mellitus [dissertation]. Boston, MA: Harvard School of Public Health, Francis A. Countway Library of Medicine, Department of Rare Books and Special Collections; 2009.
39. de Souza AZ, Zambom AZ, Abboud KY, et al. Oral supplementation with L-glutamine alters gut microbiota of obese and overweight adults: a pilot study. Nutrition. 2015; 6: 884-889.